市场调查报告书
商品编码
1511346
到 2030 年蝨子治疗市场预测:按产品、治疗方法、配方、分销管道、应用、最终用户和地区进行的全球分析Lice Treatment Market Forecasts to 2030 - Global Analysis By Product, Treatment Method, Formulation, Distribution Channel, Application, End User and By Geography |
根据 Stratistics MRC 的数据,2024 年全球蝨子治疗市场规模为 12.8 亿美元,预计将以 6.5% 的复合年增长率成长,到 2030 年将达到 17.6 亿美元。
蝨子治疗涉及消灭或去除蝨子,蝨子是通常生活在头皮、身体和生殖器上的寄生虫。这个过程通常涉及使用含有Permethrin和除虫菊酯等化学物质的药用洗髮精、乳霜和乳液来杀死蝨子及其卵(头蝨)。此外,通常建议用细齿梳子梳理头髮,以物理方式去除蝨子和蝨子卵。良好的卫生习惯和彻底清洗寝具、服装类和髮饰等个人物品对于防止再次感染和提供有效的治疗至关重要。
根据 CDC 2021 年 8 月发表的报导,美国利斯诊所已使用热空气进行了超过 75 万次有效的头蝨治疗,成功率超过 99%。
蝨子患病率高
随着蝨子流行的增加,对药用洗髮精、乳霜和特殊梳子等治疗解决方案的需求也在增加。这种需求推动了研发创新和投资,从而推出更有效、更方便的治疗方法。此外,医疗保健专业人员和公众对这一问题的认识不断提高,将导致更多地采用蝨子治疗产品,最终刺激市场的成长和扩张,以满足不断增长的需求。
对潜在副作用的担忧
对蝨子治疗潜在副作用的担忧包括皮肤刺激、过敏反应以及Permethrin和除虫菊酯等化学成分的毒性。这些担忧可能导致不愿意使用传统治疗方法、倾向于替代治疗方法或完全避免治疗。这种犹豫不决会减少对蝨子治疗药物产品的需求,从而限制市场成长,限制製造商的产生收入,并抑制市场扩张。
医疗保健支出增加
随着更多的财政资源分配给医疗保健,个人和卫生系统可以更好地购买蝨子治疗剂、洗髮精和相关产品。此外,对医疗基础设施的投资增加通常会改善宣传宣传活动、教育计划以及专门的皮肤科和感染疾病设施,所有这些都有助于增加对蝨子治疗解决方案的需求。这一趋势最终支持了蝨子治疗市场的扩张。
家庭疗法越来越受欢迎
治疗蝨子的家庭疗法越来越受欢迎,转移了药品的需求,从而削弱了市场。家庭疗法与传统治疗方法直接竞争,并减少了製药公司的销售。此外,依赖检验的家庭疗法可能会恶化并延长蝨子的侵扰。消费者偏好的这些变化减少了经过医学验证的治疗方法的采用,并阻碍了蝨子治疗药物製造商的商机,从而限制了市场成长。
COVID-19 的影响
COVID-19 大流行对蝨子治疗市场产生了多种影响。儘管卫生意识的提高和社交距离措施最初降低了蝨子发病率,但医疗保健服务的中断和经济的不确定性正在阻碍市场的成长。此外,向远距工作和虚拟学校的转变可能改变了蝨子暴露的动态。整体而言,疫情带来了供应链中断和消费行为变化等复杂性,对蝨子治疗市场产生了不可预测的影响。
预计预测期内化疗领域规模最大
化疗领域预计将出现良好的成长。化学蝨子治疗方法通常包括Permethrin或除虫菊酯等杀虫剂,它们可以瞄准并杀死蝨子及其卵。这些产品有多种形式,包括洗髮精、乳霜和乳液,可直接涂布在头皮或受影响的区域。儘管有效,但由于担心皮肤刺激和毒性等潜在副作用,不鼓励使用。此外,蝨子菌株中抗药性细菌的发展也是化学处理的一个挑战。
洗髮精领域预计在预测期内复合年增长率最高。
预计洗髮精细分市场在预测期内将以最高的复合年增长率成长。蝨子治疗洗髮精采用Permethrin和除虫菊酯等活性成分配製而成,可杀死蝨子及其卵(蝨子)。这些洗髮精涂布在湿髮上,放置一定时间,然后洗掉。根据配方的不同,可能需要重复施用才能彻底根除。儘管有效,但对化学物质接触和抗药性细菌发展的担忧正在导致替代治疗方法的发展,例如天然成分和酶基洗髮精。
由于人口密度、卫生习惯和经济发展,亚太地区预计在预测期内将占据最大的市场占有率。由于人口密度高和获得医疗保健的水平不同,各国对蝨子治疗产品的需求各不相同。一些地区的快速都市化和可支配收入的增加也推动了市场的成长。此外,政府措施和医疗保健基础设施发展在塑造亚太地区的市场前景方面发挥着至关重要的作用。
由于人们对卫生和医疗保健标准的认识不断提高,预计北美在预测期内的复合年增长率最高。儿童(尤其是学校)蝨子感染率的上升正在推动市场扩张。此外,技术进步以及有机和自然疗法的引入进一步使市场格局多样化。专注于有效性、安全性和便利性的相关人员不断创新,以满足不断变化的消费者需求并推动北美市场的持续成长。
According to Stratistics MRC, the Global Lice Treatment Market is accounted for $1.28 billion in 2024 and is expected to reach $1.76 billion by 2030 growing at a CAGR of 6.5% during the forecast period. Lice treatment involves the removal or eradication of parasitic lice infestations, typically found on the scalp, body, or pubic area. This process commonly includes the use of medicated shampoos, creams, or lotions containing chemicals like permethrin or pyrethrin to kill the lice and their eggs (nits). Additionally, combing through the hair with a fine-toothed comb to physically remove lice and nits is often recommended. Proper hygiene practices and thorough cleaning of personal items such as bedding, clothing, and hair accessories are essential to prevent reinfestation and ensure effective treatment.
According to a CDC article published in August 2021, Lice Clinics of America have accomplished administering over 750,000 effective head lice treatments through the utilization of heated air, with a success rate beyond 99 percent.
High prevalence of lice infestations
Increased instances of infestations create a greater demand for treatment solutions, including medicated shampoos, creams, and specialized combs. This demand encourages innovation and investment in research and development, leading to the introduction of more effective and convenient treatment options. Furthermore, heightened awareness of the problem among healthcare professionals and the public amplifies the adoption of lice treatment products, ultimately fueling market growth and expansion to cater to the rising needs.
Concerns about potential side effects
Concerns about potential side effects in lice treatment include skin irritation, allergic reactions, and toxicity from chemical ingredients like permethrin or pyrethrin. These worries can deter individuals from using conventional treatments, leading to a preference for alternative remedies or avoidance of treatment altogether. Such hesitations diminish market growth by reducing demand for pharmaceutical lice treatment products, thereby limiting revenue generation for manufacturers and impeding market expansion.
Rising healthcare expenditure
With more financial resources allocated to healthcare, individuals and healthcare systems are better equipped to purchase lice treatment medications, shampoos, and related products. Additionally, greater investment in healthcare infrastructure often leads to improved awareness campaigns, educational programs, and healthcare facilities specializing in dermatology and infectious diseases, all of which contribute to a higher demand for lice treatment solutions. This trend ultimately supports the expansion of the lice treatment market.
Growing popularity of home remedies
The growing popularity of home remedies for lice treatment undermines the market by diverting demand away from pharmaceutical products. Home remedies compete directly with traditional treatments, reducing sales for pharmaceutical companies. Moreover, reliance on unverified home remedies can prolong infestations, exacerbating the spread of lice. This shift in consumer preference limits market growth by diminishing the adoption of medically proven treatments and hindering revenue opportunities for lice treatment manufacturers.
Covid-19 Impact
The covid-19 pandemic has had a mixed impact on the lice treatment market. While increased hygiene awareness and social distancing measures initially reduced lice transmission rates, disruptions in healthcare access and economic uncertainty have hindered market growth. Additionally, shifts towards remote work and virtual schooling may have altered lice exposure dynamics. Overall, the pandemic has introduced complexities such as supply chain disruptions and changes in consumer behaviour, influencing the lice treatment market unpredictably.
The chemical treatments segment is expected to be the largest during the forecast period
The chemical treatments segment is estimated to have a lucrative growth. Chemical lice treatments typically contain insecticidal agents like permethrin or pyrethrin, which target and kill lice and their eggs. These products are available in various forms such as shampoos, creams, or lotions and are applied directly to the scalp or affected area. While effective, concerns about potential side effects, such as skin irritation or toxicity, have led to hesitations in usage. Resistance development among lice strains is also a growing challenge for chemical treatments.
The shampoos segment is expected to have the highest CAGR during the forecast period
The shampoos segment is anticipated to witness the highest CAGR growth during the forecast period. Lice treatment shampoos are formulated with active ingredients like permethrin or pyrethrin, which kill lice and their eggs (nits). These shampoos are applied to wet hair, left on for a specified duration, and then rinsed out. Some formulations may require repeat applications to ensure thorough eradication. While effective, concerns about chemical exposure and the development of resistance have prompted the development of alternative treatments, including natural or enzyme-based shampoos.
Asia Pacific is projected to hold the largest market share during the forecast period due to population density, hygiene practices, and economic development. With densely populated areas and varying levels of access to healthcare, demand for lice treatment products fluctuates across countries. Rapid urbanization and increasing disposable income in some areas also drive market growth. Additionally, government initiatives and healthcare infrastructure improvements play pivotal roles in shaping the market landscape across the Asia-Pacific region.
North America is projected to have the highest CAGR over the forecast period, owing to increasing awareness about hygiene and healthcare standards. Rising incidence of lice infestations, particularly among children in school settings, fuels market expansion. Moreover, technological advancements and the introduction of organic and natural remedies further diversify the market landscape. With a focus on efficacy, safety, and convenience, stakeholders continually innovate to address evolving consumer needs, fostering sustained market growth in North America.
Key players in the market
Some of the key players profiled in the Lice Treatment Market include Prestige Brands Holdings, Inc., Bayer AG, Sanofi SA, Perrigo Company plc, Insight Pharmaceuticals Corporation, Reckitt Benckiser Group plc, Arbor Pharmaceuticals, LLC, Tec Laboratories, Inc., Tyratech Inc., Quantum Health, Alliance Pharma plc, Omega Pharma, Thornton & Ross Ltd, LaCorium Health, Luminox Healthcare and ParaPRO LLC.
In April 2022, Arbor Development LLC announced the completion of the third-party clinical study that exhibits a remarkable 95% efficacy rate through the utilization of their cutting-edge, exclusive technology H.A.L.T.
In August 2021, ParaPRO announced the U.S. FDA approval for Natroba (spinosad) Topical Suspension, 0.9%, making it the inaugural product for treating scabies now accessible within the United States.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.